MedPath

A study on Siddha trail drug Maha manjishtathi kashayam(INT)Chemparuthi poo ennai (EXT)and Aasanam in patients having Psoriasis

Phase 2
Conditions
Health Condition 1: null- Thethru kuttam (Psoriasis)
Registration Number
CTRI/2018/05/013686
Lead Sponsor
Govt Siddha Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients who are having classical symptoms of Psoriasis

2.Auspitz sign positive

3.Koebners phenomenon positive

Exclusion Criteria

1.Patients of age below 18 and above 60

2.Patients having pustular Psoriasis

3.SLE

4.Leprosy

5.Pregnancy

6.Alcoholics

7.Prolonged NSAID intakers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
outcome is reduction in scaling and erythematous patches which is assesssed by PASI ScoreTimepoint: nil
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath